SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys designation of Amazon as a top pick, alongside optimism about AWS growth and AI initiatives such as Trainium, is driving attention. Many traders welcomed the sharp move, while others questioned the rally or discussed taking profits and looking for a pullback.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine is surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, strengthening the companys path toward an FDA resubmission. Traders are broadly bullish and debating a possible short squeeze, while some cite dizziness concerns and potential profit-taking.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are drawing attention after a sharp slide and technical breakdown, with traders repeatedly pointing to insider share sales as added selling pressure. Some view the sales as planned and the decline as disconnected from the companys growth, while others worry about management confidence and cite broader Southeast Asian market and oil-related risks.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-guided third-quarter results and upbeat 2027 EBITDA outlook have driven a sharp rally, with traders also pointing to short-covering and higher steel prices. The reaction is divided: bulls see room for continued gains, while skeptics warn the rally could fade and question whether the outlook can overcome the companys debt concerns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention for a sharp selloff despite the FDAs expanded ANKTIVA approval for papillary bladder cancer and encouraging long-term trial data. Traders debate whether the decline reflects sell-the-news profit-taking and broader biotech weakness, while others blame options-related pressure or short selling; concerns about revenue growth and future dilution also surface.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention after a steep post-IPO selloff, with traders citing share-unlock and insider-selling pressure, valuation and growth concerns, and broader weakness in AI and semiconductor stocks. Bulls are buying the dip and arguing the decline is overdone, while bears warn that selling could continue.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunruns continued share-price decline and heavy short interest dominate the discussion, with traders debating whether rate-sensitive solar-sector pressures and weak guidance outweigh the companys storage, virtual-power-plant, and AI data-center potential. Some see a possible short squeeze or recovery, while others expect further downside.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almonty is drawing attention after a sharp selloff around its investor day, with traders divided over CEO Lewis Blacks presentation: some found the remarks positive, while others read his delivery as a sign of undisclosed problems. Bullish holders continue to cite the Sangdong production ramp and tungsten-supply outlook, while skeptics are focused on execution and the lack of clear reassurance.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy after a sharp selloff sparked a rebound attempt, but traders debated whether the call could overcome persistent selling. The main divide is between optimism about AI-compute demand and contracted backlog, and concern that heavy debt and financing costs could threaten the business.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

FDA clearance to expand Alpha Taus U.S. recurrent glioblastoma REGAIN trial is driving attention, alongside anticipated clinical data at the SNO meeting. Traders are encouraged by the early results but are also looking ahead to confirmation in a larger cohort; completion of enrollment in the pancreatic cancer IMPACT study adds to the pipeline-catalyst discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NKE Stock Wrapped Its Best Week In 3 Months: Analyst Says Nike Will Recover From ‘Lackluster Product Development,’ Shares Undervalued 

Equity

Morningstar expects innovation, marketing, retail partnerships, and $2.5 billion in cost savings to support a long-term recovery. 


VSXY Stock Rises Overnight: Victoria’s Secret Taps Kylie Jenner’s Star Power To Spruce Up Fashion Show Buzz 

Victoria’s Secret returned to Los Angeles with a star-studded fashion show.


LULU Stock Heads For Second Week Of Decline: Lululemon Overhauls Leadership To Reignite Growth 

New product and operations leaders aim to boost Lululemon’s innovation and strengthen its connection with customers. 


‘The Big Short’ Investor Michael Burry Justifies Lululemon Tax-Loss Sale: ‘I Am Not Throwing In The Towel’ 

Michael Burry sold Lululemon to harvest tax losses and bought Deckers as a temporary proxy. 


NKE Stock Heads For Its Worst Year Ever: Nike’s 45% Plunge Tests Investor Patience As China And Core Brands Weaken

Nike’s weak China sales, struggling brands, and analyst downgrades are raising doubts about the company’s turnaround. 

NKE Stock Heads For A Weekly Loss: Morningstar Says Nike's Fresh Cost Cuts Signal A Longer Road To Recovery 

Nike stock slides as Morningstar flags a prolonged turnaround, citing weak sales, Greater China challenges, and restructuring costs.


NKE Stock Ticks Higher Overnight: Retail Stays Bullish On Nike Ahead of Q1 Earnings – 'Time To Reinvest' 

Nike faces a major earnings test as shares plunge 44% year-to-date, and short interest reaches 87 million shares. 


NKE Ticks Higher Ahead Of Q1 As Short Interest Hits Record 87M Shares — Could Earnings Squeeze The Bears?

Short sellers are sitting on an estimated $1.4 billion in paper gains this year, but a better-than-expected report could force some to cover, according to S3 Partners.

NKE Stock Heads For Another Month In The Red: Jefferies Bets On Nike's Recovery, Sees A Q1 Earnings Beat 

Jefferies sees November’s investor day supporting Nike’s turnaround. 


GAP Stock Heads For Monthly Loss Despite CEO Optimism On Old Navy — Cardi B Campaign Fails To Lift Retail Mood

Gap CEO Richard Dickson said Old Navy has diagnosed seasonal product issues and improved its assortment and marketing. 


Corgi ETF Trust I. - Corgi Lifestyle Brands ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Morningstar lowered Nike’s competitive advantage rating as rivals like Hoka and On gain ground.&nbsp;</li><li>Nike’s U.S. footwear market share dropped to 30% as retailer relationships weakened, but its strong brand keeps the stock undervalued.&nbsp;</li><li>Under CEO Elliott Hill, Nike plans to save $2.5 billion through job cuts and restructuring.</li></ul><p>Nike Inc. (NKE) stock wrapped up its best week in three months, with Morningstar saying the sportswear giant’s shares remain undervalued despite mounting competition and a weaker outlook. The analyst cut Nike’s fair value estimate but expects innovation, stronger marketing and improved retail partnerships to support a recovery.&nbsp;</p><p><a href="https://stocktwits.com/symbol/NKE">Nike stock</a> edged 0.05% lower in Monday’s premarket</p><h2 class="st-heading-2">Competition Weakens Nike’s Edge</h2><p>Morningstar analyst David Swartz reduced Nike’s economic moat rating to ‘narrow’ from ‘wide.’ The analyst believes Nike retains a powerful brand, premium pricing, and valuable relationships across professional sports. Swartz also added that Nike stock is still undervalued. However, newer rivals, including Deckers Brands (DECK) through its Hoka brand and On Holding AG (ONON), have intensified pressure on Nike’s lead in performance footwear.</p><p>Nike’s share of the U.S. sports shoe market dropped to 30% in 2025 from 40% in 2016. Morningstar said Nike’s focus on direct sales hurt relationships with retailers and caused the brand to lose some loyal customers. The analyst sees Nike as a leader in sportswear and expects it to recover from problems including “lackluster product development, soft sportswear demand, and strained relationships with wholesale accounts.”</p><h2 class="st-heading-2">Nike’s Fiscal 2027 Outlook Remains Challenging</h2><p>Morningstar expects Nike’s sales to decline 8% in fiscal 2027, compared with its previous forecast of a 2% decline. The analyst also lowered the operating margin outlook to 5.9% from 6.8% and slashed the earnings-per-share estimate to $1.16 from $1.69.</p><p>The firm now sees annual sales growth of 3% over the coming decade, down from 5%. Its peak operating margin forecast fell to 14% from 18%, reflecting mounting competition and slower growth in key markets, specifically China.</p><h2 class="st-heading-2">Innovation And Cost Cuts Drive Nike’s Turnaround Plans</h2><p>Under CEO Elliott Hill, Nike is&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-slumps-about-9-after-hours-on-a-soft-full-year-forecast-ceo-says-the-fix-will-take-time/cZD0ZX3RB0j">working</a> to strengthen retailer relationships, improve product development and reconnect with athletes and sports communities worldwide. The company is also pursuing a restructuring program designed to bring in $2.5 billion in savings over four years through job cuts and fewer management layers.</p><p>Morningstar expects Nike to redirect some of those savings toward technical development, marketing and a more responsive supply chain. The analyst believes these investments could help restore sales momentum and lift operating margins toward 14% over the next decade.</p><h2 class="st-heading-2">China And Consumer Demand Pose Risks For Nike&nbsp;</h2><p>Nike’s recovery in China remains uncertain as domestic competitors gain ground and consumer traffic weakens. Morningstar reduced its forecast for the region’s annual sales growth over the next decade to 1% from 9% previously. Tariffs, higher energy costs and inflation also threaten profit and consumer spending.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/fiscal_ai_chart_export_21_2fd96e684b.png" alt="fiscal-ai-chart-export (21).png" width="1400" height="1000"></figure><p>Despite the challenges, Morningstar expects Nike’s strong brand to help it earn returns above its 9% capital cost. The analyst also expects Nike to maintain a dividend yield above 4%, although weak results may limit buybacks.&nbsp;</p><h2 class="st-heading-2">NKE stock: Retail View&nbsp;</h2><p>On Stocktwits, retail sentiment around the stock slipped to ‘bearish’ from ‘neutral’.</p><p>NKE stock has crashed over 41% year-to-date.&nbsp;</p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/stocktwits-retail-therapy-staples-defy-market-rout-in-best-week-since-february-cracker-barrel-signet-and-vf-steal-the-show/cZx8i3jRBMB">Stocktwits Retail Therapy: Staples Defy Market Rout In Best Week Since February — Cracker Barrel, Signet And VF Steal The Show</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Nike shoes are displayed at a shoe store in Novato, California. 

Nike Inc. (NKE) stock wrapped up its best week in three months, with Morningstar saying the sportswear giant’s shares remain undervalued despite mounting competition and a weaker outlook. The analyst cut Nike’s fair value estimate but expects innovation, 

NKE Stock Wrapped Its Best Week In 3 Months: Analyst Says Nike Will Recover From ‘Lackluster Product Development,’ Shares Undervalued

Deckers Outdoor Corp.

Nike Inc

On Holding AG

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

STYL Corgi ETF Trust I. - Corgi Lifestyle Brands ETF

Fundamentals

Latest STYL News